It is currently thought that the effects of PPARγ activation on glucose homeostasis may be
due to the effect of this nuclear receptor on the production of adipocyte-derived signalling …

The current review summarizes recent experimental evidence for an intrahepatic role of
human apo C-III in promoting mobilization and utilization of triglyceride during VLDL 1 …

Hypertriglyceridemia results from accumulation of triglyceride (TG)-rich lipoproteins (TRLs)
in the circulation and is associated with increased CVD risk. ApoC-III is an apolipoprotein on …

This review aims to provide an overview on the properties of high‐density lipoproteins
(HDLs) and their cardioprotective effects. Emergent HDL therapies will be presented in the …

Lower incidence of cardiovascular disease (CVD) in the Greenland Inuit, Northern Canada
and Japan has been attributed to their consumption of seafood rich in long chain omega-3 …

This article provides a historical account of the discovery, chemistry, and biochemistry of two
ubiquitous phosphoglycerolipids, phosphatidylserine (PS) and phosphatidylethanolamine …

3-Thia fatty acids are modified fatty acids that promote hepatic peroxisome proliferation and
decrease serum triacylglycerol, cholesterol and free fatty acid levels in rats. In vivo …

Angiopoietin-like 3 (ANGPTL3) is a secreted protein with both angiogenesis and lipid
metabolism functions. We generated knockout mice that failed to express the Angptl3 gene …

KK/Snk mice (previously KK/San) possessing a recessive mutation (hypl) of the angiopoietin-
like 3 (Angptl3) gene homozygously exhibit a marked reduction of VLDL due to the …

Objective: Apo (apolipoprotein) CIII mediates the metabolism of triglyceride (TG)-rich
lipoproteins. High levels of plasma apoCIII are positively correlated with the plasma TG …